News
Programs Breast Cancer In Young Women Breast Cancer In Young Women Get Involved Partners And Sponsors Community Donate
Overview
Media Contact
Suzanne Beckmann
Director of Communications
646.257.3020
publicrelations@youngsurvival.org
Organization Profile
YSC is the premier global organization dedicated to the critical issues unique to young women with breast cancer. YSC offers resources, connections and outreach so young women feel supported, empowered and hopeful. With an interactive website, active online community and nearly 30 affiliates nationwide, YSC aims to ensure that no young woman faces breast cancer alone.
In the News
- YSC CEO Jennifer Merschdorf Participates in Breast Cancer Panel Hosted by Rep. Wasserman Schultz (March 2013)
- Liv/giant Announce Avail Inspire Design Contest Winner — YSC Constituent and Young Survivor Barb Greenlee (April 8, 2013)
Press Releases
- Young Survival Coalition Opens Registration for 2013 YSC Tour de Pink® Bike Rides — April 29, 2013
- Young Survival Coalition To Honor Founding Members at May 17 Gala In NYC — April 23, 2013
- Middletown Breast Cancer Survivor, Lori Atkinson, Appointed Chief Engagement Officer for Young Survival Coalition — March 18, 2013
- Pepsico Senior Executive Joins Board of Directors of Young Survival Coalition — January 17, 2013
- Young Survival Coalition Releases Post-Treatment Navigator — December 10, 2012
- Breast Cancer Nonprofits Announce Conference Dates for Largest International Gathering of Young Women — November 03, 2012
Statements & Position Papers
As the foremost organization serving young women affected by breast cancer, YSC is dedicated to addressing the issues and concerns of the women we serve. Using sound scientific data, YSC has published a series of position papers on issues such as ultrasound recommendations, mammography guidelines, the Breast Cancer Early Act, Magnetic Resonance Imaging (MRI) and Breast Self-Exams (BSEs). View all YSC Statements here.Financial Information
Young Survival Coalition is a 501(c)(3) not-for-profit organization. Our Annual Report and audited financial statements are available on our Financial Information page.
Corporate Support
YSC’s community of support welcomes members from the corporate world. Our Partners and Sponsors help make programs, resources and outreach available to young women who really need them.
RSS: Breast Cancer Headlines
Breast Cancer Headlines
Reasons for Hope in Metastatic Breast Cancer: A Clinical Context Report
Metastatic breast cancer remains an incurable disease. However, therapeutic developments have substantially extended the lives of many patients. Dr. Carey Anders, of the University of North Carolina in Chapel Hill, reviewed the progress and the hopes for the future in this exclusive Clinical Context interview with ALLMedPage Today staff writer Charles Bankhead.Fri, 01 Jun 2012 16:00:00 -0400
Recent Progress in the Management of Metastatic Breast Cancer, a Clinical Context Report
Advances in the treatment of breast cancer have included inroads to longer survival for patients with metastatic disease, as Edith Perez, MD, of the Mayo Clinic in Jacksonville, Fla., discusses with ALLMedPage Today staff writer Charles Bankhead in this exclusive video report.Tue, 29 May 2012 09:00:00 -0400
Triple-Negative BRCA Has Higher Mortality Risk
Women with so-called triple-negative breast cancer had nearly three times the risk of death from the disease as women with the most common form of the disease, researchers reported.Thu, 03 May 2012 15:55:32 -0400
Sorafenib Combo Ups PFS but Toxicity Is High
Sorafenib plus chemotherapy improved progression-free survival in women with advanced breast cancer, but toxicity levels were deemed 'unacceptable,' according to new trial results.Wed, 02 May 2012 11:46:38 -0400
Cryoablation OK in Breast Ca Metastasis
SAN FRANCISCO -- Cryoablation of metastatic breast cancer tumors in the liver, kidney, lung, and soft tissues appears safe and may be a cost-effective means of managing the disease, researchers said here.Wed, 28 Mar 2012 14:49:51 -0400
SABCS: Liposomal Doxorubicin Safe in Advanced Breast Ca
SAN ANTONIO -- Women with advanced breast cancer who have been pretreated with anthracyclines can be safely treated with nonpegylated liposomal doxorubicin (Myocet) along with docetaxel (Taxotere) with little effect on cardiac risk, researchers reported here.Mon, 12 Dec 2011 21:56:19 -0400
SABCS: Silent Brain Mets Common in Breast Cancer
SAN ANTONIO -- Asymptomatic brain metastases observed in magnetic resonance imaging studies appear to be common in women diagnosed with stage 4 breast cancer, researchers said here.Sat, 10 Dec 2011 10:00:00 -0400
SABCS: Surgery May Help in Advanced Breast Cancer
SAN ANTONIO -- Surgical removal of primary breast cancer tumors in women who present with metastatic disease might improve local disease control and possibly overall survival, researchers suggested here.Fri, 09 Dec 2011 13:15:56 -0400
SABCS: Bevacizumab Slows Metastatic Breast Cancer
SAN ANTONIO -- Women with metastatic HER2-positive breast cancer appeared to gain a disease-free survival benefit when bevacizumab was added to first-line therapy with trastuzumab and docetaxel, results of a large, randomized trial showed.Thu, 08 Dec 2011 17:45:36 -0400
SABCS: Novel Agent Helps Slow Advanced Breast Ca
SAN ANTONIO -- Adding the investigative agent pertuzumab to the attack against the family of HER2 genes appears to markedly slow progression of metastatic breast cancer, researchers found.Thu, 08 Dec 2011 12:34:58 -0400
SABCS: Addition of Everolimus Helps Slow Breast Cancer
SAN ANTONIO -- The combination of everolimus (Afinitor) and the aromatase inhibitor exemestane (Aromasin) extended progression-free survival in women diagnosed with metastatic breast cancer by more than four months, researchers said here.Wed, 07 Dec 2011 18:30:00 -0400
Vaccine May Slow Advance of Breast, Ovarian Cancers
Ovarian and breast cancer patients with limited tumor burden and minimal prior chemotherapy may benefit from a recombinant poxviral vaccine, according to researchers with the National Cancer Institute.Tue, 08 Nov 2011 20:06:15 -0400
ASTRO: Neoadjuvant Endocrine Tx Viable in ER Positive Cancer
MIAMI BEACH -- Neoadjuvant endocrine therapy is a potential alternative to pre-surgery cytotoxic chemotherapy in patients with locally advanced estrogen receptor-positive breast cancer, a single-center study suggested.Sat, 08 Oct 2011 12:38:10 -0400
ASTRO: Breast Cancer Type Predicts Brain Mets Outcome
MIAMI BEACH -- Survival among women with breast cancer who developed brain metastases was influenced by cancer subtype, a researcher said here.Wed, 05 Oct 2011 13:19:41 -0400
ECCO-ESMO: Drug Combo Works in Triple-Negative Breast Cancer
STOCKHOLM -- In clinical practice, bevacizumab (Avastin) plus paclitaxel (Taxol) works about as well for patients with triple-negative metastatic breast cancer as it does for those without triple-negative disease, researchers said here.Fri, 30 Sep 2011 15:55:19 -0400
Post-Treatment Navigator
View, download or orderInfo Just for you
Newly Diagnosed
Resource Kit
